Implanet (STU:IM11) Accounts Payable: €10.80 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:IM11 Implanet SA STU:IM11
31 GF Score
Price €0.16
GF Value €0.07
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Implanet Accounts Payable?

Implanet STU:IM11 -5.24% 31 Accounts Payable is €10.80 Mil as of Dec. 2025. GuruFocus rates STU:IM11 with a GF Score™ of 31/100 and a GF Value™ of €0.07 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Implanet's Accounts Payable for the quarter that ended in Dec. 2025 was €10.80 Mil.

Implanet's quarterly Accounts Payable increased from Dec. 2024 (€6.34 Mil) to Jun. 2025 (€10.00 Mil) and increased from Jun. 2025 (€10.00 Mil) to Dec. 2025 (€10.80 Mil).

Implanet's annual Accounts Payable increased from Dec. 2023 (€2.87 Mil) to Dec. 2024 (€6.34 Mil) and increased from Dec. 2024 (€6.34 Mil) to Dec. 2025 (€10.80 Mil).

Implanet Accounts Payable Historical Data

* Premium members only.

The historical data trend for Implanet's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Implanet Accounts Payable Chart

Implanet Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.72 2.82 2.87 6.34 10.80

Implanet Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.87 3.80 6.34 10.00 10.80
STU:IM11
31GF Score
Implanet SA STU:IM11
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Implanet Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of €10.80 Mil mean?
Implanet (STU:IM11) has a Accounts Payable of €10.80 Mil as of Dec. 2025. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Implanet and its competitors.
Is Implanet's Accounts Payable too high?
Implanet's current Accounts Payable is €10.80 Mil. Overall, Implanet has a GF Score™ of 31/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Implanet's Accounts Payable compare to ABT and SYK?
Implanet's Accounts Payable of €10.80 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Medical Devices & Instruments company?
A good Accounts Payable depends on the Medical Devices & Instruments industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Implanet and its competitors. Implanet's current Accounts Payable is €10.80 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Implanet stock overvalued right now?
Based on GuruFocus' analysis, Implanet (STU:IM11) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.07, compared to a current price of €0.16 — trading 122% above its estimated fair value. The current Accounts Payable is €10.80 Mil. Implanet's overall GF Score™ is 31/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Implanet (STU:IM11), the current Accounts Payable is €10.80 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Implanet (STU:IM11) Overvalued in 2026?

Based on GuruFocus' analysis, Implanet stock appears to be overvalued. The current stock price of €0.16 is trading 122% above its estimated GF Value™ of €0.07. GuruFocus considers Implanet to be Significantly Overvalued.

Key valuation signals for STU:IM11:

  • Accounts Payable: €10.80 Mil
  • GF Value™: €0.07 vs. price of €0.16 (122% above fair value)
  • GF Score™: 31/100 with 4 warning signs

No single metric tells the full story. See the STU:IM11 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Implanet Business Description

Other Exchanges ALIMP:France
Address Technopole Bordeaux Montesquieu, Allee Francois Magendie, Martillac, FRA, 33650
Implanet SA designs produce and sell medical implants and devices used in orthopedic surgery. Its products include prosthetic knees, spinal bracing systems, intersomatic cages, pins, suture threads, screws, and anchors. The company operates in a single segment - the commercialization of orthopedic implants. It derives Majority of its geographical revenue from France.
31GF Score

Get the complete analysis for STU:IM11

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.16
Price
€0.07
GF Value